Related Experiment Video
Updated: Feb 8, 2026
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Interventional heart failure: a new field
1Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Insights
Interventional heart failure (HF) therapies address unmet needs, offering device-based solutions to reduce mortality and improve patient compliance beyond traditional medications.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Device Development
Background:
- Despite advances, heart failure (HF) treatment faces challenges, particularly for HF with preserved ejection fraction and right ventricular failure.
- High morbidity and mortality persist in HF patients, indicating significant unmet clinical needs.
- Current pharmacotherapies for HF often require complex regimens and patient adherence, presenting treatment barriers.
Purpose of the Study:
- To review the current unmet needs in interventional heart failure (HF) therapy.
- To analyze lessons learned from past successes and challenges in developing device-based HF treatments.
- To explore emerging interventional therapies and future considerations for HF management.
Main Methods:
- Review of existing literature and clinical data on interventional HF therapies.
- Analysis of device development pathways and clinical trial outcomes.
- Discussion of current and future trends in device-based HF treatment.
Main Results:
- The field of interventional cardiology for HF is rapidly expanding due to persistent unmet needs.
- Device-based therapies offer potential advantages, including reduced polypharmacy and improved patient compliance.
- Novel interventional approaches are emerging, addressing limitations of current HF management.
Conclusions:
- Interventional therapies represent a growing and necessary frontier in managing heart failure.
- Continued innovation in device development is crucial to overcome current treatment limitations.
- Addressing future challenges will be key to realizing the full potential of interventional HF treatments.
Abstract:
With the rapid expansion of interventional therapies for structural heart disease, it is no surprise that the field of interventional heart failure (HF) is now an established reality. Why is there a need for interventional treatment of HF? Despite critical advances in the treatment of some forms of HF, there are still major unmet needs in the HF field (e.g., HF with preserved ejection fraction and right ventricular failure), and HF-related morbidity and mortality remain high. Furthermore, there are several advantages to device-based therapies for HF: they may help reduce polypharmacy and the need for patient compliance with pharmacotherapies, both of which continue to plague the treatment of HF. For these reasons and others, there has been a plethora of development within the interventional HF field, with therapies ranging from interatrial shunt devices to left ventricular partition devices. Here we discuss the current unmet need for interventional HF therapies, lessons learned from prior successes and challenges in the development of device-based HF therapeutics, novel interventional therapies on the horizon for HF patients, and future challenges that will be critical for all those in the field to consider when developing interventional therapies for HF.
Related Concept Videos
01:30Heart Failure VII: Nursing Interventions
01:22Heart Failure VI: Adjunct Therapies
01:29Heart Failure II: Pathophysiology
01:27Heart Failure I: Introduction
01:17Pathophysiology of Heart Failure
01:22Heart Failure Drugs: Diuretics